Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis

Experimental Cell Research

Volumn 260, Issue 2, 2000, Pages 248-256

  Halicka, H Dorota ^a   Bedner, Elzbieta ^a,b   Darzynkiewicz, Zbigniew ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptotic bodies; Camptothecin; Caspase activation; Incorporation of BrU; Laser scanning cytometry; Nucleolus; Phagocytosis; Pyronin Y; TNF

Indexed keywords

7 AMINODACTINOMYCIN; CAMPTOTHECIN; DNA; DNA TOPOISOMERASE INHIBITOR; FLUOROCHROME; LIGAND; MONOCLONAL ANTIBODY; PYRONINE; RNA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CONTROLLED STUDY; DNA DAMAGE; DNA DEGRADATION; DNA DETERMINATION; DNA PACKAGING; HISTOCHEMISTRY; HUMAN; HUMAN CELL; PHAGOSOME; PRIORITY JOURNAL; RNA ANALYSIS; SEGREGATION ANALYSIS;

EID: 0034329421     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5027     Document Type: Article

References (47)

1. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview
3. Apoptosis: Its significance in cancer and cancer therapy
4. Apoptosis, oncosis, and necrosis. An overview of cell death
5. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
6. A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome
7. Activation of a 15-kDa endonuclease in hypoxia/reoxygenation injury without morphologic features of apoptosis
8. Apoptosis-related functional features of the DNase I-like family of nucleases
9. Apoptotic DNA fragmentation
10. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD
11. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
12. Control of DNA degradation
13. NUC-1, a Caenorhabditis elegans DNase II homolog, functions in an intermediate step of DNA degradation during apoptosis
14. An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes
15. Activation of the INF-inducible enzyme RNase L causes apoptosis of animal cells
16. The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosis
17. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis
18. Caspase-3-dependent and -independent degradation of 28 S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement
19. Nuclear RNA is extruded from apoptotic cells
20. Still immunodetectable nuclear RNPs are extruded from the cytoplasm of spontaneously apoptotic thymocytes
21. Flow cytometric measurement of RNA synthesis using bromouridine labeling and bromodeoxyuridine antibodies
22. Immunoseparation and immunodetection of nucleic acids labeled with halogenated nucleotides
23. Flow cytometric analysis of RNA synthesis by detection of bromouridine incorporation
24. Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and pyronin Y
25. Application of pyronin Y in cytochemistry of nucleic acids
26. Slide-based laser scanning cytometry
27. Laser scanning cytometry. A new instrumentation with many applications
28. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): Correlation with DNA fragmentation
29. Analysis of apoptosis by laser scanning cytometry
30. The cell cycle effects and induction of apoptosis by 5-bromouridine in cultures of human leukemic MOLT-4 and HL-60 cell lines and mitogen stimulated normal lymphocytes
31. Changes in cell nuclei during S phase: Progressive chromatin condensation and altered expression of the proliferation-associated nuclear proteins Ki-67, p-105, cyclin/PCNA, and p34
32. The nucleolus
33. Drug and metabolite-induced perturbations in nuclear and nucleolar function. A review
34. Movement and localization of RNA in the cell nucleus
35. Nucleolar segregation as an early marker for DNA damage: An experimental study in rats treated with 4-hydroxyaminoquinolone 1-oxide
36. Nucleolar segregation during apoptosis of hematopoietic stem cell line FDCP-Mix
37. Relationship between the pharmacological activity of antitumor drugs Ametantrone and Mitoxantrone (Novatrone) and their ability to condense nucleic acids
38. Ultrastructure of nuclei of cisplatin-treated C6 glioma cells undergoing apoptosis
39. Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells
40. Cleavage of poly(ADP-ribose) polymerase measured in situ in individual cells: Relationship to DNA fragmentation and cell cycle position during apoptosis
41. Full activation of RNaseL in animal cells requires binding of 25A within ankyrin repeats 6 to 9 of this interferon-inducible enzyme
42. The fate of U1 snRNP during anti-Fas induced apoptosis: Specific cleavage of the U1 snRNA molecule
43. Heteronuclear ribonucleoproteins C1 and C2, components of the spliceosome, are specific targets of interleukin 1beta-converting enzyme-like proteases in apoptosis
44. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3
45. Behavior of nuclear proteins during the course of apoptosis in camptothecin-treated HL-60 cells
46. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
47. Ribonucleoprotein complexes as autoantigens